Takeda Announces Candidates for New Directors

May 15, 2020

Osaka, Japan, May 13, 2020, --- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has decided the candidates for new Directors which will be proposed to the 144^th Ordinary General Meeting of Shareholders in June 2020. The candidates are as follows;

Candidates for Non-Audit and Supervisory Committee Directors

Name	Category		Current Role
Christophe Weber	Internal	Existing	Representative Director, President & Chief Executive Officer
Masato Iwasaki	Internal	Existing	Director, President, Japan Pharma Business Unit
Andrew Plump	Internal	Existing	Director, President, Research & Development
Constantine Saroukos	Internal	Existing	Director, Chief Financial Officer
Masahiro Sakane	External	Existing	External Director, Chair of the Board Meeting
Olivier Bohuon	External	Existing	External Director
Jean-Luc Butel	External	Existing	External Director
Ian Clark	External	Existing	External Director
Yoshiaki Fujimori	External	Existing	External Director
Steven Gillis	External	Existing	External Director
Shiro Kuniya	External	Existing	External Director
Toshiyuki Shiga	External	Existing	External Director

Candidates for Audit and Supervisory Committee Directors

Name	Category		Current Role
Yasuhiko Yamanaka	Internal	Existing	Director, Full-time Audit & Supervisory Committee member
Koji Hatsukawa	External	Existing	External Director, Chairperson of Audit & Supervisory Committee
Emiko Higashi	External	Existing	External Director, Audit & Supervisory Committee member
Michel Orsinger	External	Existing	External Director, Audit & Supervisory Committee member

Media Contact:
Kazumi Kobayashi
[email protected]
+81 (0) 3-3278-2095